Mary Cushman Spoke with WPTZ About New Research Showing Incidence of Cognitive Impairment Prediction
Mary Cushman, University Distinguished Professor and Vice Chair at University of Vermont, shared her first post on LinkedIn:
“My 1st LinkedIn post!
I was pleased to speak with WPTZ about our new research showing that circulating laboratory markers of neurodegeneration can predict the incidence of cognitive impairment over 12 years in initially healthy people.
It is amazing to me that damage to the brain can be detected in the blood, and detect pathology occurring years before cognitive problems start.
Associations were larger than I thought they’d be.
This research comes from the REGARDS Study, which we have been conducting since 2003.”
Title: Circulating Biomarkers of Neurodegeneration and Risk of Cognitive Impairment
Authors: Russell P. Sawyer, Aleena Bennett, Jessica Blair, Suzanne E. Judd, Nels Olson, Virginia J. Howard, Nicole D. Armstrong, D. Leann Long, Hyacinth I. Hyacinth, Jennifer J. Manly, Mary Cushman
Read full paper here.
Never miss the latest with Hemostasis Today.
-
Sep 26, 2026, 18:01Kalyan Roy: Blood Group Chimerism as a Rare Cause of ABO Discrepancy
-
Sep 26, 2026, 17:34Arwa Z. Al-Riyami: Join ISBT and Advance Your Career
-
Sep 26, 2026, 16:58Paul Whiteley: Iron Deficiency and Behavioral Problems in Children With Autism
-
Sep 26, 2026, 16:41Matthew Smeds: Management of Thoracic Endograft Thrombosis and Mesenteric Embolization
-
Sep 26, 2026, 16:04Isabelle Feldhaus: What the New ASH Iron Deficiency Guidance Means for Care
-
Sep 26, 2026, 15:55Francesca Palandri: The R-NAT Score Developed in Ruxolitinib-Treated MF Patients
-
Sep 26, 2026, 15:49Alex Ehsan: Antiphospholipid Syndrome – A Practical Guide
-
Sep 26, 2026, 15:42Michael Tadao Inouye: The Next Frontier in Genomic Population Health
-
Sep 26, 2026, 15:32Katariina Öörni: Familial Hypercholesterolaemia in Children Why Early Diagnosis Matters